CARLSBAD, Calif., Aug. 17 /PRNewswire/ -- Medex, a global leader in critical care medical products, has announced that it has been awarded a five-year FSS portfolio agreement by the Department of Veteran Affairs. Medex estimates this award as representing up to $20 million total in expenditures by the Department of Veterans Affairs over the life of the contract.
This agreement will make Medex syringe pumps, pressure monitoring products, and a comprehensive line of infusion disposables available to more than 170 Veterans Affairs Medical Centers across the United States. Steve Glover, Medex VP of Corporate Accounts, stated, “We look forward to providing Veterans Affairs Medical Centers with our broad spectrum of high-quality and cost-effective products.”
One example is the Medfusion(TM) 3500 Syringe Pump with PharmGuard(TM) Medication Safety Software, leading-edge technology designed to reduce medication delivery errors by encouraging programmable upper and lower dose limits. Continued Glover, “These are innovative solutions that address the needs of these facilities and their patients while providing tremendous value. We are extremely enthusiastic regarding this partnership.”
About Medex
Medex manufactures and markets critical care medical products for use in a variety of diagnostic and therapeutic procedures. Medex offers solutions for the entire continuum of care, providing critical care systems and products to hospitals, health care systems and alternate healthcare settings in more than 75 countries through a global sales force and distribution network. Headquartered in Carlsbad, California, the company employs approximately 2,000 people worldwide.
For more information, please visit http://www.medex.com/. Forward-Looking Statements
This news release contains certain “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. Detailed information about such risk factors is set forth in the Registration Statement on Form S-4 filed by Medex with the Securities and Exchange Commission on April 7, 2004 including, but not limited to, those risks and uncertainties listed in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Medex undertakes no obligation to update, alter or release publicly any revisions to its forward-looking statements, whether as a result of new information, subsequent events or developments.
Medex, Inc.
CONTACT: Gregory Aranaga, Director, Corporate Communications of Medex,Inc., +1-760-602-4455, garanaga@medex.com
Web site: http://www.medex.com/
